Efficacy of second-line chemotherapy after a first-line triplet in patients with metastatic colorectal cancer

BACKGROUND: Exposing patients with metastatic colorectal cancer (mcrc) to all three active chemotherapeutic agents (oxaliplatin, irinotecan, fluorouracil) has improved survival. The benefit of second-line chemotherapy after a first-line triplet is not clearly defined. We evaluated the efficacy of se...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Curr Oncol
Main Authors: Bazarbashi, S., Hakoun, A.M., Gad, A.M., Elshenawy, M.A., Aljubran, A., Alzahrani, A.M., Eldali, A.
Formato: Artigo
Idioma:Inglês
Publicado em: Multimed Inc. 2019
Assuntos:
Original Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6380651/
https://ncbi.nlm.nih.gov/pubmed/30853806
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3747/co.26.4217
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados